Children Tumors Research

mianerifoundation@gmail.com

Join Us

SHOP

Our commitment

The mission of Mia Neri Foundation Onlus is to support research aimed at discovering cures for children’s tumors, prevention and information, involving children and young people in raising awareness and understanding of suffering and the value of life.

The funds raised are allocated according to the indications of a scientific committee made up of experts of proven competence.

Collaboration agreement between the Mia Neri Foundation Onlus Association and the Regina Elena National Cancer Institute

Prof. Gennaro Ciliberto, Scientific Director of the Institute of the Regina Elena National Cancer Institute and Prof. Giovanni Neri, President of the Mia Neri Foundation Association (in the photo) have signed a collaboration agreement with the aim of strengthening the commitment of the Association in research for the discovery of new treatments against children’s tumors.

Help us support research in the field of pediatric oncology.

Researchers and research projects funded by the Association

Scientific works

Scientific works published with the support of the Mia Neri Foundation Association

De Novo A-to-I RNA Editing Discovery in lncRNA. Silvestris DA, Scopa C, Hanchi S, Locatelli F, Gallo A. Cancers (Basel). 2020 Oct 13;12(10): E2959.
Quantifying RNA Editing in Deep Transcriptome Datasets. Lo Giudice C, Silvestris DA, Roth SH, Eisenberg E, Pesole G, Gallo A, Picardi E. Front Genet. 2020 Mar 6;11:194.
Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster. Piazzi M, Bavelloni A, Gallo A, Faenza I, Blalock WL. Int J Mol Sci. 2019 Jun 3;20(11):2718.
The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer. Tassinari V, Cesarini V, Silvestris DA, Gallo A. Biochim Biophys Acta Gene Regul Mech. 2019 1862: 291-300
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Tassinari V, Tomaselli S, Ianniello Z, Silvestris DA, Cesarini V, Ceci Ginistrelli L, Martini M, De Luca G, Ricci Vitiani L, Fatica A, Locatelli F, Gallo A. Genome Biology 2021 22:51 https://doi.org/10.1186/s13059-021-02271-9
ADAR2 knockdown enhances glioblastoma cell proliferation, migration and anchorage-independent growth Federica Galeano, Valeriana Cesarini, Domenico Alessandro Silvestris, Valentina Tassinari, Franco Locatelli and Angela Gallo (Cancers under revision)

DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis. Barbara Rivera et al. J Clin Invest 2020 130:1479-1490
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Rebecca D. Chernock, Barbara Rivera et al. Modern Pathology https://doi.org/10.1038/s41379-020-0458-7
Manipulating the Metabolism to Improve the Efficacy of CART-Cell Immunotherapy. Marsha Pellegrino, Francesca Del Bufalo, Biagio De Angelis, Concetta Quintarelli, Ignazio Caruana and Emmanuel de Billy. Cells 2021, 10, 14. https://dx.doi.org/10.3390/cells10010014
Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids? Giulia Regazzo…Maria Giulia Rizzo. 2020 Blood Review
Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers. A.B. Diaz Mendez, E. Tremante, S. Brandner, M.G. Rizzo Neuropathol Appl Neurobiol. 2021, 47:471–487.
Urinary expression of let-7c cluster as noninvasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. M. Spagnuolo…G. Regazzo…M.G. Rizzo Journal of Experimental & Clinical Cancer Research 2020, 39:68

Help us support research in the field of pediatric oncology.

Link

Where we are

Via F. Ferrara 50
00191 Rome (RM)
Italy

mianerifoundation@gmail.com

Crediti